Evonik Specialty Chemicals (Shanghai) Co., Ltd.
USPTO PatentsView assignee record - 6 granted patents across 13 technology areas, recorded in grant years 2019–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08L (Compositions OF Macromolecular Compounds).
The verdict
According to USPTO PatentsView, Evonik ranks #40,125 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 13 technology areas.
- #40,125
- of 49,997 US assignees by volume
- Top 45%
- by Innovation Score (37.0/100)
- 18.2
- avg claims per patent
- +400%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R40125 · Foreign Corporation #40,125 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #40,125/49,997
- PHOTO-FINISH Everising Machine
- CPC-FOCUS C08L · 13 areas
- INNOV-THIN 37.0/100
- CLAIMS-RICH 18.2 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +400% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Everising Machine Company (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Evonik’s 37.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Evonik
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Evonik Specialty… · this assignee
Evonik Specialty… · this assignee
37 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Evonik's Innovation Score is 37.0/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Evonik?
Each dot is one of Evonik’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Evonik’s own 18.2 claims/patent is ABOVE the 10.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Evonik's grants concentrate
Evonik Specialty Chemicals (Shanghai) Co., Ltd. is a focused PatentsView assignee: 13 CPC subclasses with 83.3% of grants classified under C08L (Compositions OF Macromolecular Compounds). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2019. By volume, Evonik sits between Everising Machine Company and ExQ, LLC.
Evonik's three-year grant acceleration
Evonik Specialty Chemicals (Shanghai) Co., Ltd. shows 3 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Evonik's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Everising Machine
Everising Machine Company
6 patents
- Evo
Evo, Inc.
6 patents
- Evofem
Evofem, Inc.
6 patents
- Evolve Range Solu…
Evolve Range Solutions, Inc.
6 patents
- Evosport AB
Evosport AB
6 patents
- Evox Therapeutics
Evox Therapeutics Ltd
6 patents
- Exb Asset Managem…
ExB Asset Management GmbH
6 patents
- Exq
ExQ, LLC
6 patents
- Evonik Specialty… ◀
Evonik Specialty Chemicals (Shanghai) Co., Ltd.
6 patents
What this shows Evonik holds 6 patents at rank #40,121, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Evonik
By rank, the assignees closest to #40,121 in granted patent volume.
- Everising Machine Company #40,117 · 6 patents
- Evo, Inc. #40,118 · 6 patents
- Evofem, Inc. #40,119 · 6 patents
- Evolve Range Solutions, Inc. #40,120 · 6 patents
- Evosport AB #40,122 · 6 patents
- Evox Therapeutics Ltd #40,123 · 6 patents
- ExB Asset Management GmbH #40,124 · 6 patents
- ExQ, LLC #40,125 · 6 patents
Leaders in C08L (Compositions OF Macromolecular Compounds)
Other assignees with the most granted patents in Evonik's primary technology class.
Evonik's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
37 Top 45% higher than 55% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 16.7% |
| 2020 | 1 | 16.7% |
| 2021 | 1 | 16.7% |
| 2022 | 2 | 33.3% |
| 2023 | 1 | 16.7% |
Which technologies does Evonik Specialty Chemicals (Shanghai) Co., Ltd. patent most?
Top 13 of 13 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Evonik Specialty Chemicals (Shanghai) Co., Ltd.'s patent record in context - here's where to go next.
- Evonik Specialty Chemicals (Shanghai) Co., Ltd.'s lead technology class is C08L (Compositions OF Macromolecular Compounds), 83.3% of its portfolio - see every assignee active in that class. Explore C08L
- Ranked #40,125 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Evonik Specialty Chemicals (Shanghai) Co., Ltd. against Everising Machine Company, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 37.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.